| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.38 | $101.34 (0%) | 🛒 Add to cart |
| 60 | $2.71 | $202.69 $162.55 (20%) | 🛒 Add to cart |
| 90 | $2.50 | $304.03 $224.76 (26%) | 🛒 Add to cart |
| 120 | $2.37 | $405.37 $284.97 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $608.06 $407.38 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $912.09 $592.01 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.17 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.75 $70.24 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.33 $91.31 (7%) | 🛒 Add to cart |
| 180 | $0.74 | $147.50 $132.45 (10%) | 🛒 Add to cart |
| 270 | $0.72 | $221.25 $195.66 (12%) | 🛒 Add to cart |
| 360 | $0.72
Best per pill | $295.00 $257.87 (13%) | 🛒 Add to cart |
Similar products
More info:
diltiazem
Diltiazem hydrochloride is a calcium channel blocker of the benzothiazepine class, available in various formulations including immediate-release tablets, extended-release capsules, and intravenous preparations. As a cardiovascular agent, it occupies a unique therapeutic niche with multiple mechanisms that distinguish it from other antianginal and antihypertensive medications. I remember when we first started using diltiazem extensively in our cardiology practice back in the early 2000s - we had this 68-year-old patient, Robert, who presented with both hypertension and stable angina.
calan
Calan, known generically as verapamil, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance for decades due to its multifaceted mechanism and reliable efficacy profile. Unlike dihydropyridine calcium channel blockers that predominantly affect vascular smooth muscle, verapamil exhibits significant activity on both cardiac and vascular tissues, making it particularly valuable for arrhythmia management alongside hypertension and angina treatment.
Cardizem: Effective Blood Pressure and Heart Rhythm Control - Evidence-Based Review
Cardizem, known generically as diltiazem, is a calcium channel blocker primarily prescribed for managing cardiovascular conditions like hypertension, chronic stable angina, and certain arrhythmias. It works by relaxing blood vessels and reducing the heart’s workload, which helps improve blood flow and control heart rate. Available in various formulations including immediate-release tablets, extended-release capsules, and intravenous forms, Cardizem is a cornerstone in cardiology due to its efficacy and relatively favorable side effect profile.
Colchicine: Targeted Anti-Inflammatory Action for Gout and FMF - Evidence-Based Review
Colchicine is a plant-derived alkaloid medication originally extracted from the autumn crocus (Colchicum autumnale). It’s one of the oldest remedies still in use, with historical records dating back to ancient Egypt for treating joint swelling and pain. In modern medicine, colchicine is primarily classified as an anti-inflammatory agent with a unique mechanism distinct from NSAIDs or corticosteroids. Its main clinical role centers around treating and preventing acute gout flares and managing Familial Mediterranean Fever (FMF).
Cordarone: Life-Saving Rhythm Control for Refractory Arrhythmias - Evidence-Based Review
Cordarone is a class III antiarrhythmic medication containing amiodarone hydrochloride, primarily used for managing severe ventricular and supraventricular arrhythmias when other treatments have failed. Its unique iodine-rich structure and multifaceted electrophysiological effects make it one of the most potent yet complex antiarrhythmics in clinical practice. 1. Introduction: What is Cordarone? Its Role in Modern Medicine Cordarone, known generically as amiodarone hydrochloride, represents a critical tool in the cardiologist’s arsenal for managing life-threatening arrhythmias.
inderal
Propranolol hydrochloride, marketed under the brand name Inderal, represents one of the foundational beta-blockers in cardiovascular and neurological medicine. As a non-selective beta-adrenergic antagonist, it competitively blocks catecholamine effects at both β1 and β2 adrenergic receptors, producing a wide spectrum of therapeutic actions from heart rate control to anxiety management. What’s fascinating about this molecule isn’t just its mechanism—it’s how we’ve continuously discovered new applications decades after its initial development.
isoptin
Verapamil hydrochloride, marketed under the brand name Isoptin, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance for decades due to its unique electrophysiological properties and versatile applications. Unlike dihydropyridine calcium antagonists that predominantly affect vascular smooth muscle, Isoptin exhibits significant activity on both cardiac myocytes and nodal tissue, creating a distinct therapeutic profile that continues to challenge and fascinate clinicians.
lopressor
Lopressor, known generically as metoprolol tartrate, represents one of the foundational beta-blockers in cardiovascular pharmacotherapy. Developed initially by Ciba-Geigy (now Novartis), this selective β1-adrenergic receptor antagonist has been a workhorse in managing hypertension, angina, and post-myocardial infarction care since its approval. What’s fascinating isn’t just its mechanism—which we’ll explore—but how its tartrate salt formulation created distinct dosing flexibility that later succinate formulations couldn’t fully replicate for certain acute indications. I remember our cardiology department’s transition from using mostly propranolol to adopting Lopressor in the early 1990s—the reduction in bronchospasm complaints from COPD patients was noticeable almost immediately.
nimotop
Nimodipine is a dihydropyridine calcium channel blocker with selective cerebrovascular activity, originally developed by Bayer and now available as generic nimodipine. What makes it fascinating - and frankly quite different from other calcium blockers - is its peculiar affinity for cerebral arteries over peripheral vessels. We initially thought it was just another antihypertensive, but the cerebroselectivity turned out to be the game-changer. I remember when we first started using it in the neuro ICU back in the late 90s - we had this 72-year-old patient, Mrs.